Benjamin K Chan
Overview
Explore the profile of Benjamin K Chan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
2924
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kunisch F, Campobasso C, Wagemans J, Yildirim S, Chan B, Schaudinn C, et al.
Nat Commun
. 2024 Oct;
15(1):8572.
PMID: 39362854
Spread of multidrug-resistant Pseudomonas aeruginosa strains threatens to render currently available antibiotics obsolete, with limited prospects for the development of new antibiotics. Lytic bacteriophages, the viruses of bacteria, represent a...
2.
Bernabeu-Gimeno M, Pardo-Freire M, Chan B, Turner P, Gil-Brusola A, Perez-Tarazona S, et al.
Med
. 2024 Jun;
5(9):1096-1111.e6.
PMID: 38917792
Background: Cystic fibrosis (CF) patients are prone to recurrent multi-drug-resistant (MDR) bacterial lung infections. Under this scenario, phage therapy has been proposed as a promising tool. However, the limited number...
3.
Wurstle S, Lee A, Kortright K, Winzig F, An W, Stanley G, et al.
Sci Rep
. 2024 Feb;
14(1):2657.
PMID: 38302552
Bacteriophage therapy is one potential strategy to treat antimicrobial resistant or persistent bacterial infections, and the year 2021 marked the centennial of Felix d'Hérelle's first publication on the clinical applications...
4.
Yeager J, Gomez-Jaramillo A, Ortiz-Prado E, Calvopina M, Chan B
Expert Rev Anti Infect Ther
. 2024 Jan;
22(1-3):19-23.
PMID: 38217395
Introduction: Antimicrobial resistance in Latin America is a growing concern in both human and non-human animal populations. The economic burden that is likely to be imposed through increased resistance will...
5.
Hahn A, Sami I, Chaney H, Koumbourlis A, Del Valle Mojica C, Cochrane C, et al.
J Investig Med High Impact Case Rep
. 2023 Jul;
11:23247096231188243.
PMID: 37515541
Cystic fibrosis (CF) is an important monogenic disease that affects more than 70 000 people worldwide. Defects of the CF transmembrane conductance regulator gene lead to dehydrated viscous secretions that...
6.
Schwarz J, An W, Theroux A, Vargas L, Chan B, Turner P, et al.
Microbiol Resour Announc
. 2023 Jun;
12(7):e0010723.
PMID: 37272828
We present the structural and functional annotation of Escherichia coli bacteriophage 55, which has a genome length of 170,393 bp, with 219 predicted genes.
7.
Schwarz J, Chan B, Turner P, Burmeister A
Microbiol Resour Announc
. 2023 May;
12(6):e0010623.
PMID: 37191527
We present the annotated genome sequence of Escherichia coli bacteriophage 107, a T4-like bacteriophage. Phage 107 has a genome length of 167,509 bp and 287 predicted genes.
8.
Wurstle S, Hapfelmeier A, Karapetyan S, Studen F, Isaakidou A, Schneider T, et al.
Diagnostics (Basel)
. 2023 Mar;
13(5).
PMID: 36900138
Ascitic fluid infection is a serious complication of liver cirrhosis. The distinction between the more common spontaneous bacterial peritonitis (SBP) and the less common secondary peritonitis in patients with liver...
9.
Haidar G, Chan B, Cho S, Hughes Kramer K, Nordstrom H, Wallace N, et al.
Transpl Infect Dis
. 2023 Mar;
25(2):e14041.
PMID: 36864824
Background: There is increased interest in bacteriophage (phage) therapy to treat infections caused by antibiotic-resistant bacteria. A lung transplant recipient with cystic fibrosis and Burkholderia multivorans infection was treated with...
10.
Winzig F, Gandhi S, Lee A, Wurstle S, Stanley G, Capuano I, et al.
Yale J Biol Med
. 2022 Dec;
95(4):413-427.
PMID: 36568830
The rise of antimicrobial resistant (AMR) bacteria is a global public health threat. AMR bacteria pose a challenging clinical problem, particularly for those with cystic fibrosis (CF) who are predisposed...